INCY logo

INCY
Incyte Corp.

5,591
Mkt Cap
$19.8B
Volume
13.00
52W High
$112.29
52W Low
$61.11
PE Ratio
13.97
INCY Fundamentals
Price
$98.82
Prev Close
$99.13
Open
$98.74
50D MA
$95.46
Beta
0.57
Avg. Volume
1.45M
EPS (Annual)
$6.41
P/B
3.51
Rev/Employee
$1.81M
$16,297.46
Loading...
Loading...
News
all
press releases
Incyte Announces More Than 20 Abstracts Accepted for Presentation at the European Hematology Association (EHA) 2026 Congress
Incyte (Nasdaq:INCY) today announced that data from key programs in its Hematology and Oncology franchises will be presented at the European Hematology Association (EHA) 2026 Congress, to be held June 11 - 14, 2026, in Stockholm, Sweden. The breadth of the data that will be showcased at the 2026...
Business Wire·2d ago
News Placeholder
More News
News Placeholder
Mirum's Q1 Earnings & Revenues Beat Estimates, 2026 View Raised
MIRM beats Q1 earnings and revenue estimates as Livmarli and bile acid drugs fuel growth, prompting a higher 2026 sales outlook.
Zacks·7d ago
News Placeholder
Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura (ruxolitinib) Cream in Adults with Moderate Atopic Dermatitis
Incyte (Nasdaq:INCY) today announced final 24-week data from the Phase 3 TRuE-AD4 study evaluating the efficacy and safety of Opzelura (ruxolitinib) cream in adults with moderate atopic dermatitis...
Business Wire·7d ago
News Placeholder
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Incyte Corporation (Nasdaq:INCY) announced today that it granted equity inducement awards to Suketu (Suky) Upadhyay, the Companys new Executive Vice President and Chief Financial Officer, pursuant to...
Business Wire·8d ago
News Placeholder
Why Incyte (INCY) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·8d ago
News Placeholder
Here's Why Incyte (INCY) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·9d ago
News Placeholder
Horizon Investments LLC Sells 83,430 Shares of Incyte Corporation $INCY
Horizon Investments LLC lowered its stake in shares of Incyte Corporation (NASDAQ:INCY - Free Report) by 75.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,722 shares of the biopharmaceutical...
MarketBeat·9d ago
News Placeholder
18,960 Shares in Incyte Corporation $INCY Acquired by PFA Pension Forsikringsaktieselskab
PFA Pension Forsikringsaktieselskab bought a new position in shares of Incyte Corporation (NASDAQ:INCY - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 18,960 shares of the biopharmaceutical company's stock, valu...
MarketBeat·9d ago
News Placeholder
Danske Bank A S Boosts Stake in Incyte Corporation $INCY
Danske Bank A S boosted its stake in Incyte Corporation (NASDAQ:INCY - Free Report) by 29.1% during the fourth quarter, according to the company in its most recent filing with the SEC. The...
MarketBeat·9d ago
News Placeholder
Why Incyte (INCY) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·10d ago
<
1
2
...
>

Latest INCY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.